Jinghua Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China
精华制药
No insider purchase over the last 90 days. The latest, by 薛倩玉, was filed 24 May 2022.
Jinghua Pharmaceutical Group Co., Ltd.: what insiders have been doing
This page follows insider dealings at Jinghua Pharmaceutical Group Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Jinghua Pharmaceutical Group Co., Ltd. has had no insider filing for more than a year; the last one goes back to 24 May 2022.
Over the whole record (from 2022), the tally stands at 1 purchase and 1 sale.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -32.7%Entry CN¥15.27 · Close at T+365 CN¥10.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Jinghua Pharmaceutical Group Co., Ltd.
Jinghua Pharmaceutical is a company focused on the manufacturing of pharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
